William Brennen

Assistant Professor

20032018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Prodrugs Medicine & Life Sciences
Mesenchymal Stromal Cells Medicine & Life Sciences
Prostate Medicine & Life Sciences
Fibroblasts Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Heterografts Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2018

Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer

Kumar, B., Rosenberg, A., Choi, S. M., Fox-Talbot, K., Demarzo, A. M., Nonn, L., Brennen, W., Marchionni, L., Halushka, M. K. & Lupold, S., Dec 1 2018, In : Scientific Reports. 8, 1, 7189.

Research output: Contribution to journalArticle

MicroRNAs
Prostate
Prostatic Neoplasms
Tumor Microenvironment
Epithelium

Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise

Krueger, T. E. G., Thorek, D. L. J., Denmeade, S. R., Isaacs, J. T. & Brennen, W., Sep 1 2018, In : Stem Cells Translational Medicine. 7, 9, p. 651-663 13 p.

Research output: Contribution to journalReview article

Mesenchymal Stromal Cells
Pharmaceutical Preparations
Neoplasms
Cell Tracking
Tropism

Mesenchymal stem cells and the embryonic reawakening theory of BPH

Brennen, W. & Isaacs, J. T., Jan 1 2018, (Accepted/In press) In : Nature Reviews Urology.

Research output: Contribution to journalArticle

Mesenchymal Stromal Cells
Prostate
Growth
Autoantigens
Stem Cells

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models

Navone, N. M., van Weerden, W. M., Vessella, R. L., Williams, E. D., Wang, Y., Isaacs, J. T., Nguyen, H. M., Culig, Z., van der Pluijm, G., Rentsch, C. A., Marques, R. B., de Ridder, C. M. A., Bubendorf, L., Thalmann, G. N., Brennen, W., Santer, F. R., Moser, P. L., Shepherd, P., Efstathiou, E., Xue, H. & 11 othersLin, D., Buijs, J., Bosse, T., Collins, A., Maitland, N., Buzza, M., Kouspou, M., Achtman, A., Taylor, R. A., Risbridger, G. & Corey, E., Dec 1 2018, In : Prostate. 78, 16, p. 1262-1282 21 p.

Research output: Contribution to journalArticle

Heterografts
Prostatic Neoplasms
Fluorescence In Situ Hybridization
Androgens
Prostate
alpha-Macroglobulins
Peptide Hormones
Prostate-Specific Antigen
Prostatic Neoplasms
Serum